Jan 9 (Reuters) - Twist Bioscience Corp TWST.O :
* TWIST BIOSCIENCE AND ASTELLAS ENTER INTO MULTITARGET
ANTIBODY
DISCOVERY RESEARCH COLLABORATION
* TWIST BIOSCIENCE - WILL BE ELIGIBLE TO RECEIVE UP TO $11
MILLION
USD PER PRODUCT THROUGH PAYMENTS ASSOCIATED WITH SPECIFIC
CLINICAL, COMMERCIAL MILESTONES
* TWIST BIOSCIENCE CORP - TWIST WILL ALSO BE ELIGIBLE TO
RECEIVE
ROYALTY PAYMENTS ON PRODUCT SALES
* TWIST BIOSCIENCE CORP - ASTELLAS WILL BE RESPONSIBLE FOR
DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION OF ANY SUCH
PRODUCTS
* TWIST BIOSCIENCE CORP - UNDER TERMS OF AGREEMENT, TWIST
WILL
CONDUCT ANTIBODY DISCOVERY ACTIVITIES AGAINST MULTIPLE TARGETS
IDENTIFIED BY ASTELLAS
Source text for Eikon: ID:nBw30QCwPa
Further company coverage: TWST.O
((Reuters.Briefs@thomsonreuters.com;))